Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2023-11-03
Featured Millennium Pharmaceuticals manuals

Millennium Pharmaceuticals CN 101772507 B Proteasome Inhibitor Patent
This is the Chinese granted invention patent CN 101772507 B (application no. 200780100142.3, filed 2007.08.06, granted 2012.12.12), filed by Millennium Pharmaceuticals of Massachusetts, USA, with inventors Edward J. Olhava and Mihaela D. Danca. It is a PCT national-phase entry (PCT/US2007/017440, published as WO 2009/020448) and runs 3 pages of claims plus 19 pages of description.
The patent concerns boronic acid and boronic ester compounds described as useful proteasome inhibitors, pharmaceutical compositions containing them, and methods of using those compositions to treat diseases. The claims define formula (I) compounds or their pharmaceutically acceptable salts or boronic anhydrides, list numerous named [(1R)-1-({[(benzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acids and their mannitol esters, and include a composition claim and a use claim for preparing a medicament for treating cancer. The background section reviews earlier peptide boronic acid and proteasome inhibitor literature. This manual is written in Chinese.
Covers: Claims (权利要求书) · Technical Field (技术领域) · Background (背景技术) · Description (说明书)
Latest Millennium Pharmaceuticals manuals
Millennium Pharmaceuticals CN 101772507 B Proteasome Inhibitor Patent
Other 23 pages · 562 KB · ZHGranted Chinese patent CN 101772507 B from Millennium Pharmaceuticals on boronic acid and boronic ester compounds as proteasome inhibitors and their drug uses.
Questions answered in Millennium Pharmaceuticals manuals
What compounds does patent CN 101772507 B cover?
It covers boronic acid and boronic ester compounds described as useful proteasome inhibitors, including many specifically named [(1R)-1-({[(benzoyl)amino]acetyl}amino)-3-methylbutyl]boronic acids, their pharmaceutically acceptable salts and boronic anhydrides.
From: Millennium Pharmaceuticals CN 101772507 B Proteasome Inhibitor Patent
What use of the compounds is claimed?
The claims state a use of the compounds for preparing a medicament for treating cancer.
From: Millennium Pharmaceuticals CN 101772507 B Proteasome Inhibitor Patent
